Get started
Author

Pascale Lévy

Observed names: LEVY-BRIANT, Pascale, Levy, P., P. Lévy, Pascale Levy, Pascale Lévy, Pascale Lèvy, Pascale Lévy-Briant
ORCID: 0000-0002-6171-0175
Observed ORCID: 0000-0002-6171-0175
OpenAlex ID: A5104110157
Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.
2004 · Pascale Lévy, Dominique Vidaud, et al. · Molecular Cancer · 100
PDF
Expression of stathmin family genes in human tissues: non-neural-restricted expression for SCLIP
2003 · Ivan Bièche, Alexandre Maucuer, et al. · Genomics · 77
PFMG2025–integrating genomic medicine into the national healthcare system in France
2025 · Caroline Abadie, Aldja Abderrahmane, et al. · The Lancet Regional Health - Europe · 64
PDF
Identification of Genes Potentially Involved in the Increased Risk of Malignancy in NF1-Microdeleted Patients
2010 · Eric Pasmant, Julien Masliah-Planchon, et al. · Molecular Medicine · 57
PDF
Microarray-Based Identification of Tenascin C and Tenascin XB , Genes Possibly Involved in Tumorigenesis Associated with Neurofibromatosis Type 1
2007 · Pascale Lévy, Hugues Ripoche, et al. · Clinical Cancer Research · 53
Molecular Profiles of Neurofibromatosis Type 1-Associated Plexiform Neurofibromas
2004 · Pascale Lévy, Ivan Bièche, et al. · Clinical Cancer Research · 36
Differential Expression ofCCN1/CYR61,CCN3/NOV,CCN4/WISP1, andCCN5/WISP2in Neurofibromatosis Type 1 Tumorigenesis
2009 · Eric Pasmant, Nicolas Ortonne, et al. · Journal of Neuropathology & Experimental Neurology · 18
Le métier de conseiller(ère) en génétique
2022 · Audrey Mallet, Pascale Lévy, et al. · Les Tribunes de la santé · 2
Approche moléculaire des MPNSTs dans la neurofibromatose de type 1 : vers l’identification de marqueurs diagnostiques et pronostiques
2008 · D. Vidaud, P. Lévy, et al. · Archives de Pédiatrie · 2
Caractéristiques génétiques: de la prescription au rendu des résultats et rôle des conseillers en génétique
2025 · Émilie Consolino, David Geneviève, et al. · Revue Francophone des Laboratoires
Supplementary Tables 1-4 from Microarray-Based Identification of Tenascin C and Tenascin XB, Genes Possibly Involved in Tumorigenesis Associated with Neurofibromatosis Type 1
2023 · Pascale Lévy, Hugues Ripoche, et al.
PDF
Supplementary Figures 1-3 from Microarray-Based Identification of Tenascin C and Tenascin XB, Genes Possibly Involved in Tumorigenesis Associated with Neurofibromatosis Type 1
2023 · Pascale Lévy, Hugues Ripoche, et al.
PDF
Supplementary Figure Legends 1-3 from Microarray-Based Identification of Tenascin C and Tenascin XB, Genes Possibly Involved in Tumorigenesis Associated with Neurofibromatosis Type 1
2023 · Pascale Lévy, Hugues Ripoche, et al.
Data from Microarray-Based Identification of Tenascin C and Tenascin XB, Genes Possibly Involved in Tumorigenesis Associated with Neurofibromatosis Type 1
2023 · Pascale Lévy, Hugues Ripoche, et al.
Le parcours complexe de la mise à la nomenclature des nouveaux tests. Exemple du dépistage prénatal non invasif de la trisomie 21
2016 · P. Lévy, D. Sanlaville, et al. · Revue de médecine périnatale
[Sounding board. First trimester Down syndrome screening in France].
2012 · Brigitte Simon-Bouy, Dominique Royère, et al. · PubMed
P54 PGD activity in France: the French specificities
2010 · S. Di Costanzo, P. Lévy, et al. · Reproductive BioMedicine Online
PDF
Génétique moléculaire des tumeurs bénignes et malignes des gaines nerveuses périphériques chez les patients atteints de neurofibromatose de type 1
2008 · Pascale Lévy-Briant · OpenGrey (Institut de l'Information Scientifique et Technique)
Works count: 20
Citation count: 410
H-index: 7
I10-index: 7
Year
Topic
Type